<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860335</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1417</article-id><article-id pub-id-type="other">EPV0788</article-id><article-id pub-id-type="pii">S0924933824014172</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Cerebral-cognitive reserve: concept and functions of the cerebral-cognitive reserve</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sidenkova</surname><given-names>A.</given-names></name><xref rid="aff3128" ref-type="aff"/></contrib></contrib-group><aff id="aff3128">Psychiatry, <institution>Ural State Medical University</institution>, <city>Yekaterinburg</city>, <country>
Russian Federation</country></aff><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1392">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S681</fpage><lpage>S682</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824014172a.pdf"/><abstract><sec id="sec7616"><title>Introduction</title><p>The modern understanding of AD allows us to consider it through the constructs of&#x000a0;&#x0201c;vulnerability&#x0201d; and &#x0201c;stability&#x0201d; of the brain as a dynamic system of dialectical interaction between&#x000a0;the pathogenic process and the protective process that prevents neurodegeneration. The concept&#x000a0;of cognitive reserve (CR) is based on observations of discrepancy between the degree of brain&#x000a0;pathology and the severity of clinical manifestations. The concept of &#x0201c;reserve&#x0201d; was proposed to&#x000a0;describe the resistance of the brain to a developing damage caused by a pathological process.&#x000a0;Stern (2002) considered CR as a protective factor that modifies the impact of brain pathology on&#x000a0;cognitive function. The researchers have defined CR as an ability to optimize cognitive function&#x000a0;through differential involvement of structures or neural networks of the brain into brain activity.</p></sec><sec id="sec7617"><title>Objectives</title><p>A systematic review of scientific studies has been conducted</p></sec><sec id="sec7618"><title>Methods</title><p>The review&#x000a0;includes an analysis of&#x000a0;full-text literature sources.</p></sec><sec id="sec7619"><title>Results</title><p>Several possible directions of CR influence on cognitive functions have been described:<list list-type="order"><list-item><p>CR may reduce the risk of MCI or dementia through mechanisms, which do not depend on the&#x000a0;level of neurodegenerative pathological changes in the brain.</p></list-item><list-item><p>CR can interact with the markers of brain pathology or healthaffectingthe future cognitive&#x000a0;decline or risk of progression. It has been found that smaller volumes or thickness in some AD vulnerable areas of the brain represent a stronger risk factor for cognitive impairment in people with low CR than in people with higher CR. CR protective effects on clinical outcomes reduce as the number of damaged neurons increases.</p></list-item><list-item><p>The protective effect of CR increasesduring late AD onset and at a low rate of the damaged&#x000a0;substrate accumulation.</p></list-item><list-item><p>CR changes the relationship between genetic factors and aging withclinical and cognitive&#x000a0;outcomes. The relationship between age and AD pathology level or age-related structural&#x000a0;changes in the brain may weaken in people with higher CR
</p></list-item></list></p></sec><sec id="sec7620"><title>Conclusions</title><p>The concept of cerebral-cognitive reserve actualizes the problem of the search for compensatory mechanisms of cognitive deficit in AD, the assessmentof the structure of the reserve, the development and&#x000a0;implementationof programs to maintain the reserve, the preventionof its depletion, starting from the preclinical stage of the disease, which can prevent the transformation of preclinical manifestations of AD into cognitive disorders</p></sec><sec id="sec7621"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>